Diabetes and cardiometabolic advertisers operate in a sensitive-condition category where the targeting that improves efficiency can also breach platform policy and privacy law. Done well, programmatic delivers scalable, measurable reach across the open web and connected TV. Done poorly, it burns budget on bots and leaves you one pixel away from a compliance incident. We create a programmatic engine that scales safely and connects spend to qualified patients.
The Challenge
The targeting that makes programmatic effective is precisely what platforms and privacy laws restrict
Diabetes and cardiovascular disease are sensitive health conditions, and the major platforms restrict targeting people by them, while privacy regulators scrutinize any use of health-inferred data. Advertisers who lean on condition-based audiences to sharpen efficiency are building on ground that can disappear or trigger enforcement. In cardiometabolic care this is not a corner case – it is the center of the channel. Scaling programmatic safely means building reach without the sensitive targeting most playbooks assume.
One misconfigured pixel can expose protected health information without anyone realizing it
Tracking pixels and tags on patient-facing pages can quietly transmit health-related data to ad platforms, and health advertisers have faced serious consequences for exactly this. The leak usually happens because marketing moved fast and no one audited what the tags actually send. In cardiometabolic care, where pages often touch conditions and intake, this exposure is real and expensive. It has to be found and fixed before spend scales, not after a regulator or a headline finds it for you.
Programmatic supply is packed with fraud and low-quality inventory that drains your budget
The open programmatic marketplace is riddled with bot traffic, made-for-advertising sites, and low-quality placements that consume budget without reaching a real patient. Without curated inventory and fraud controls, a meaningful share of spend never touches a human, let alone a qualified cardiometabolic buyer. At the CAC levels this category carries, that waste is not a rounding error. A clean supply path is the difference between scaled reach and scaled waste.
You are optimizing for impressions and clicks rather than qualified patients
Programmatic platforms optimize toward whatever signal you feed them, and if that signal is clicks, the algorithm finds cheap clicks that never convert. In a category with a long, considered patient journey, click optimization drives volume that looks good and retains terribly. The channel has to be pointed at qualified signups and retained patients, not surface engagement. Without that, programmatic scales the wrong thing efficiently.
How We Can Help
We begin with a compliance and privacy audit before any money is spent. We map every pixel and tag across your patient-facing properties, identify where health-related data might leak to advertising platforms, and correct the tagging so the channel can scale safely. In cardiometabolic advertising, this is step zero, because increasing spend on top of a leaking pixel only increases the liability.
Next, we build audiences that reach your patient without depending on restricted sensitive targeting. We combine contextual placement, first-party data activated with privacy-safe methods, and lookalike modeling based on your own converters rather than platform health segments. In a sensitive category, this is both the compliant route and, increasingly, the more durable approach as third-party signals decline.
We then clean up the supply path. We curate inventory through vetted marketplaces and private deals, implement fraud and brand-safety controls, and remove the made-for-advertising junk that consumes spend without reaching a person. Across display, native, and connected TV, we favor placements where a real cardiometabolic buyer could plausibly be – not simply the lowest-cost impression available.
For execution, we steer the channel toward qualified outcomes. We send platforms qualified-signup signals rather than clicks, structure campaigns so algorithms optimize for the patient instead of the tire-kicker, and control frequency so a considered health decision is supported, not overwhelmed. We operate within your current acquisition mix, ensuring programmatic supports paid search and social instead of competing against them.
For measurement, we connect spend to qualified pipeline and retention through clean attribution that honors the category's privacy constraints. We report cost per qualified signup by inventory source and monitor retention among programmatic-sourced patients, because inexpensive volume that churns represents a loss here. Performance and compliance are measured together, never traded against each other.
What sets us apart is that we operate programmatic as embedded partners responsible for both performance and the compliance posture – not as media buyers pursuing efficiency without visibility into privacy risk. In this category, the two responsibilities cannot be split, and we own both.
What we deliver
- Pixel and tag privacy audit across patient-facing properties, with tagging fixed before spend scales
- Compliant audience strategy using contextual, privacy-safe first-party, and converter-based lookalike targeting – no restricted health segments
- Curated supply path with fraud and brand-safety controls across display, native, and connected TV
- Outcome-based campaign structure optimized to qualified signups with managed frequency for a considered decision
- Privacy-respecting attribution – cost per qualified signup by source and retention of programmatic-sourced patients
In cardiometabolic advertising, performance and compliance are one job. The sensitive-condition targeting that appears to be the efficient route is what gets your pixel flagged and wastes your budget – a durable engine relies instead on contextual, first-party, and converter-based signals.
Our Methodology
We operate programmatic through a safety-first 90-day sprint. The opening 30 days focus on compliance and foundation: we audit every tag and pixel, repair leaks, and create a compliant audience and supply strategy that never uses restricted health segments. Days 30 to 60 cover the live scale test: we launch curated display, native, and connected TV campaigns optimized for qualified signups, implement fraud controls, and review cost per qualified signup by source each week. Days 60 to 90 focus on consolidation: we direct budget toward the sources and formats generating qualified, retained patients, then provide a compliant, documented programmatic playbook.
What distinguishes this approach from a traditional programmatic agency is that we take responsibility for privacy posture and performance as one. Most media buyers optimize for efficiency while assuming compliance is managed elsewhere, which is precisely how health advertisers get into trouble. We make the audit a non-negotiable step zero, develop audiences that remain compliant and durable as third-party signals decline, and judge the channel by qualified pipeline rather than impressions.
Our Working Process
The opening 30 days cover audit and foundation. We map and repair your tags and pixels, develop a compliant audience and supply strategy, and establish outcome-based tracking. You will not see significant spend during this period, because scaling before the compliance posture is clean is how incidents happen in this category.
Days 30 to 60 focus on the live test. We launch curated display, native, and connected TV campaigns, implement fraud and brand-safety controls, and assess cost per qualified signup by inventory source each week. We bring specific reallocation recommendations to those reviews, not dashboards alone. From your team, we require access to ad accounts, analytics, and web properties, along with a privacy or legal contact for the audit.
Days 60 to 90 cover consolidation and handoff. We shift budget toward proven formats and sources, document the compliant configuration, and deliver a playbook your team can operate. Most engagements last three to six months, with extensions when we are actively expanding into new formats such as connected TV or into new geographies.
Our cadence includes a weekly working session and an asynchronous performance-and-compliance update. We remain embedded in the privacy posture and spend data instead of reporting from the sidelines, which allows the channel to keep scaling safely.
- Cost per qualified signup by inventory source
- Retention of programmatic-sourced patients
- Verified clean, fraud-controlled supply
- Documented, compliant tagging and audience setup
If your diabetes & cardiometabolic health company needs programmatic advertising leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does a programmatic advertising engagement cost for diabetes and cardiometabolic health companies?
We bill a fixed monthly management fee covering strategy, compliance, and optimization, in addition to your placement media budget. The fee range varies based on the number of formats you use and the current condition of your tagging and compliance posture.
How soon will we see results from a programmatic advertising engagement?
The compliance audit creates value within the first few weeks by closing exposure you might not have realized existed. Performance data begins to arrive after the live test starts, typically within the first 45 days, then stabilizes across the 90-day sprint as we focus budget on sources that convert qualified patients.
How will the programmatic advertising team work with our existing staff?
We integrate into your acquisition and analytics stack instead of operating as a separate vendor. We require access to your web properties, analytics, and ad accounts, as well as a privacy or legal contact for the tagging audit.
How is Winston Francois different from a traditional programmatic agency?
Most programmatic agencies pursue efficiency while treating compliance as somebody else's responsibility, which is precisely how health advertisers expose protected data and face penalties. We jointly own performance and the privacy posture, make the pixel audit a non-negotiable step zero, and create audiences that remain compliant without restricted health targeting. We also evaluate the channel on qualified pipeline and retention, not impressions. In this category, these disciplines cannot be separated, so we manage them as one.
How is ROI measured for a programmatic advertising engagement?
We calculate cost per qualified signup by inventory source and monitor retention among programmatic-sourced patients, with attribution that honors the category's privacy constraints. We also confirm the supply is clean and protected by fraud controls, because unmeasured waste creates a hidden negative return. We benchmark results against your pre-engagement acquisition economics to make the improvement tangible. Preventing even one privacy incident is itself a significant return, though an uncomfortable one to quantify.
What kind of diabetes and cardiometabolic health company is best suited to this service?
This service is designed for companies with roughly 5M to 100M in ARR that must expand acquisition reach beyond paid search and social alone and can measure a qualified signup or conversion. It performs best when you are prepared to fund a compliant foundation instead of pursuing the cheapest impressions. If you are pre-product-market-fit or still cannot measure conversions, a more targeted channel is generally a better place to begin. Our first step is a strategy call and a brief review of your current tagging.
